Tech article
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Publisher description: Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
TechCrunch | Oct 14, 2026 | Kate Park
Automated excerpt
The startup’s flagship product, GastroScreen, is a human intestinal organoid model that it sells to pharmaceutical, biotech, food, and chemical companies for testing drugs and other compounds. Altis Biosystems develops stem cell-derived intestinal models, while InSphero offers patient-derived intestinal organoids for gastrointestinal toxicity testing. Intero doesn’t use AI to build its organoids.
Selected automatically from source text; not independently written or fact-checked. Read the original for full context.